Ab Science Stock-Based Compensation Growth & History (AB)
Ab Science's stock-based compensation was €2.1M for fiscal 2025.
View full Ab Science company overviewAb Science annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €2.1M | €1.1M | +105.60% |
| 2024 | 2024-12-31 | €1.0M | €412,000 | +68.10% |
| 2023 | 2023-12-31 | €605,000 | €472,000 | +354.89% |
| 2022 | 2022-12-31 | €133,000 | −€125,000 | −48.45% |
| 2021 | 2021-12-31 | €258,000 | €163,000 | +171.58% |
| 2020 | 2020-12-31 | €95,000 | — | — |
Ab Science stock-based compensation trends
Over the last five fiscal years, Ab Science's stock-based compensation increased from €95,000 to €2.1M, a change of €2.0M.
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
reported stock-based compensation
TickerStat standardizes share-based compensation reported in company official filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ab Science source filings ↗